June 14, 2012—The Health Resources and Services Administration (HRSA) is seeking a contractor to review the Office of Pharmacy Affairs' (OPA) 340B covered entity audit reports and "provide feedback on any identified issues," according to a June 11 notice posted on the Federal Business Opportunities Web site. In addition, the "pre-solicitation" notice states that the … [Read more...]
Emails Shed Light on How 340B Inpatient Expansion Was Dropped From Health Reform
February 2010 exchange between PhRMA execs describe phone call that apparently sealed the dealJune 12, 2012—White House and pharmaceutical industry communications released by House Energy and Commerce Committee Republicans late last week shed light on the negotiations over closing the Part D "donut hole" and expanding the 340B drug discount program in the days leading up to final passage of the Affordable Care Act (ACA) in early 2010. According to a Feb. 21, 2010 … [Read more...]
Illinois Measure Will Bring Changes to 340B
State will require all eligible providers to enroll and forbid them from carving Medicaid outJune 5, 2012—Illinois is set to become the first state to require all of its 340B-eligible health care providers to participate in the federal drug discount program and then pass along to the state nearly all of their savings on 340B drugs administered or dispensed to Medicaid patients. Gov. Pat Quinn has said he will sign S.B. 2840, which state lawmakers sent to him on May … [Read more...]
340B Program Integrity Inquiry Continues
Members of Congress raise questions about a health system's and hospital's use of drug discountsMay 29, 2012—Members of Congress concerned about 340B oversight and program integrity are continuing their inquiries, turning their attention to a Georgia health system and an Alabama hospital. Two members of the House Energy and Commerce Subcommittee on Health recently sent a letter to the Health Resources and Services Administration (HRSA) asking it to audit … [Read more...]
OPA Publishes Two New Policy Releases
Updates non-discrimination policy and clarifies 340B eligibility within ACOsMay 25, 2012—The Office of Pharmacy Affairs (OPA) posted two new policy releases on its Web site yesterday. The first is an update to OPA’s non-discrimination policy requiring drug manufacturers to treat 340B providers the same as non-340B providers when manufacturers develop alternate allocation systems for drugs in short supply. OPA had issued a policy release on its … [Read more...]
Welcome to the New & Improved Drug Discount Monitor
Important information about resetting your password and our new featuresMay 24, 2012—Today we're re-launching the Drug Discount Monitor with a new look and new features to enhance your reading experience. You'll now be able to get instant email alerts whenever we publish new articles, subscribe to a Monitor news feed, follow us on Twitter, and do keyword searches of our previous stories dating back to February 2009. To access our improved Web site, … [Read more...]
CMS Reviewing Comments on Medicaid Drug Pricing Proposed Rule
Providers and drug manufacturers weigh in on 340B-specific issuesMay 22, 2012—Regulations implementing health care reform's Medicaid drug rebate provisions should encourage "shared savings" arrangements between 340B covered entities and Medicaid agencies, provider groups urged in comments filed with the Centers for Medicare and Medicaid Services (CMS). Drug manufacturers, meanwhile, asked CMS to exempt any prices charged to 340B covered … [Read more...]